Home › Testicular Cancer › New York › New York City
Testicular Cancer clinical trials in New York City, NY
5 studies for Testicular Cancer are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
RecruitingPhase 1
- Memorial Sloan Kettering Cancer Center, New York
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
RecruitingPhase 1
- Icahn School of Medicine at Mount Sinai, New York
Brodalumab in the Treatment of Immune-Related Adverse Events
RecruitingPhase 1
- Columbia University Irving Medical Center, New York
Germ Cell Tumor and Testicular Tumor DNA Registry
RecruitingObservational studyHealthy volunteers welcome
- Memorial Sloan Kettering Cancer Center, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, New York
About Testicular Cancer
Testicular cancer mainly affects young men between the ages of 20 and 39. Symptoms include pain, swelling, or lumps in your testicles or groin area.
More about Testicular Cancer on MedlinePlus
Testicular Cancer trials in other cities
- Durham, NC4 studies
- Nashville, TN4 studies
- Dallas, TX3 studies
- Birmingham, AL3 studies
- Indianapolis, IN3 studies
- Edison, NJ3 studies
- Omaha, NE3 studies
- Baldwin Park, CA3 studies
- Atlanta, GA3 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.